Lipitor Lawsuit For Diabetes In Women: Summary Of Allegations Targeting Pfizer
Written by Stephen Fields on April 30, 2015
Lipitor lawsuit claims are being filed by women who allege the blockbuster statin caused them to become diabetic. The controversy centers around whether the manufacturer, Pfizer Inc., sufficiently warned consumers or doctors about the possible risk. Plaintiffs in more than 2,000 cases pending in federal and state courts claim Pfizer should have known about it given 20 years of scientific research showing a potential Lipitor diabetes side effects connection.
The litigation targeting the drug maker is heating up. The first Lipitor diabetes lawsuit trials begin with a bellwether case which was recently selected to be heard by a jury in October 2015. Lipitor lawsuit attorneys will be watching that case closely to see how jurors respond to evidence and testimony. Federal Lipitor claims are being handled through multidistrict litigation in South Carolina (MDL 2502).
If you used Lipitor and were later diagnosed with type 2 diabetes, you’re not alone. Thousands of women believe they have experienced the same terrible circumstance. Call our Lipitor attorneys today at 1-888-578-4755 and find out whether you can join the Lipitor MDL and recover compensation for your illness.
Allegations Being Made By Lipitor Plaintiffs:
Failure To Warn Women About The Lipitor Diabetes Risk
Pfizer had a responsibility to warn women about a Lipitor and Type 2 diabetes risk and that use of Lipitor might not only cause a dangerous rise in their glucose levels, but also new-onset diabetes. The company neglected to do so. It wasn’t until the U.S. Food and Drug Administration mandated labeling changes for the drug in 2012 that Pfizer took action.
But even today, Pfizer’s “warning” is unclear. It’s obfuscated in confusing language. Rather than stating that the use of Lipitor might cause diabetes, the company notes that “increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors.”
Intentionally Misrepresenting Lipitor’s Safety Profile
Plaintiffs are accusing Pfizer of being liable for their Lipitor diabetes complications by deliberately making false statements about the safety and effectiveness of its medication. They claim the manufacturer should have been aware of the diabetes risk. Rather than alerting consumers and health care providers, it promoted Lipitor as not dangerous.
Deliberate Concealment Of Details About The Diabetes Risk
Information about the potential Lipitor and type 2 diabetes connection has been available since the mid-1990s. Several studies have shown that drugs in its class (statins) raise blood glucose levels and expose users to a higher risk of becoming diabetic. The studies were published in scientific journals, which means Pfizer had access to them.
The company had a responsibility to monitor scientific literature for data indicating a risk of undisclosed side effects. It had a duty to investigate such data and notify the public and medical community if the risk was real.
As noted earlier, Pfizer failed to warn consumers and doctors until 2012, when the FDA announced mandatory labeling changes. In the years prior, the drug maker is accused of choosing to conceal information about the danger of new-onset diabetes.
Lack Of Post-Marketing Surveillance To Monitor Side Effects
Once a prescription drug has been approved for sale by the FDA, its manufacturer is expected to perform post-marketing surveillance. This is an important step toward protecting the public’s safety. Side effects sometimes go unidentified during clinical trials. Post-marketing surveillance is performed to identify adverse effects that surface following FDA approval.
The lawsuits targeting Pfizer claim the company didn’t do enough to uncover Lipitor’s dangerous side effects in the years leading up to 2012. Rather than verifying the drug’s safety, the company focused its efforts on heavily promoting it to doctors and consumers.
Prioritizing Profits Above The Public’s Safety
Pfizer has spent billions of dollars advertising Lipitor as the solution to high cholesterol levels and the risk of heart disease. By doing so, it has reaped the largest profit stream in the history of prescription drugs. Lipitor has generated more than $130 billion in revenue since 1996.
Plaintiffs allege the manufacturer put its quest for profit ahead of the public’s safety. Instead of warning women about the possibility of developing diabetes, the company kept silent and enjoyed a multibillion-dollar annual windfall.
For these reasons, thousands of women across the U.S. have chosen to sue Pfizer for Lipitor and Diabetes side effects, in an effort to hold the manufacturer accountable for their actions.
How To File A Lipitor Diabetes Lawsuit For Compensation
The first step is to call us toll-free at 1-888-578-4755. Our Lipitor lawsuit attorneys will review the circumstances surrounding your case and determine if you’re eligible to file a claim for compensation.
The case review is free and without obligation. We’re here to listen and help you sort through your legal options. If you decide to file a Lipitor diabetes lawsuit against Pfizer, there are no legal fees unless we win your case and obtain a financial recovery for you.
The Lipitor Diabetes claim-filing deadline is approaching. Call our offices today to find out the deadline for your state. If you decide to move forward with a claim, we’ll aggressively represent your interests and fight to secure the compensation you deserve.